IP Library Granted Patent US 10,227,418
Granted Patent B2
US 10,227,418 · App. 15/399,506 · Granted Mar 12, 2019

Neukinase, a downstream protein of neuregulin

Inventor: Mingdong Zhou (Shanghai, CN)
Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
C07K16/40A61K38/45C12N9/1205C12Q1/485G01N33/68G01N33/6842G01N2333/4756
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,227,418
App. No.
15/399,506
Granted
Mar 12, 2019
Kind
B2
Abstract

The present invention relates to neukinase, a downstream protein kinase in the neuregulin signaling pathway. In certain aspects, the present invention provides isolated neukinase-encoding nucleic acids, neukinase polypeptides, oligonucleotides that hybridize to neukinase nucleic acids, and expression vectors containing neukinase-encoding sequences. The present invention further provides isolated host cells, antibodies, transgenic non-human animals, compositions, and kits relating to neukinase. In other aspects, the present invention further provides methods of identifying predisposition to cardiac dysfunction, methods of detecting the presence of neukinase, neukinase nucleic acid, methods of screening for agents which affect neukinase activity, and methods of modulating neukinase activity.

Claims (7)

1. A method of modulating neukinase gene expression in a cell of a mammal, the method comprising contacting the cell with an isolated polynucleotide comprising SEQ ID NO:4 or its complementary strand.

2. The method of claim 1 , wherein the polynucleotide encodes a polypeptide having SEQ ID NO:2 or SEQ ID NO:25.

3. The method of claim 1 , wherein the neukinase gene expression is increased.

4. The method of claim 3 , wherein the increased neukinase gene expression increases the level of expression of a polypeptide of SEQ ID NO:2 or SEQ ID NO:25.

5. The method of claim 1 , wherein the isolated polynucleotide consists of SEQ ID NO:4 or its complementary strand.

6. The method of claim 1 , wherein the cell is a cardiac cell.

7. The method of claim 1 , wherein the modulation is in vitro modulation.

Continuity (4)
Division 11894542 · Aug 20, 2007
Provisional Application 60921655 · Apr 2, 2007
Provisional Application 60839388 · Aug 21, 2006
Related Publication 20170313784A1 · Nov 2, 2017